Piramal Pharma (PPLPHARMA.NSE) Q3 2025 Earnings

28JulConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.81
-0.14
0.53
1.2

Details

Expected EPS
-0.6933391395840001
Actual EPS
-0.80973914112
Surprise EPS
-0.12
Surprise Percent
+16.79%

Description

Piramal Pharma (PPLPHARMA.NSE) has reported earnings of -0.80973914112 per share for Q3 2025.

0 Comments

Share your thoughts